Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Miyakoshi J et al. | 1994 | intact cell/cell culture, human leukemia cell lines (HL60RG, CCRF-CEM9), GM0637 cells (normal human fibroblast cell line), TAT2SF cells (human Louis-Bar syndrome fibroblast cell line) | magnetic field, 50/60 Hz, also other exposures without EMF | 400 mT |
Verheyen GR et al. | 2003 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz, co-exposure | 80–800 µT |
Jung JH et al. | 2017 | intact cell/cell culture, human mesenchymal stem cells | magnetic field, low frequency, 50/60 Hz | - |
Koziorowska A et al. | 2017 | intact cell/cell culture, human neonatal fibroblast BJ | 50/60 Hz, magnetic field, low frequency, signals/pulses | 2.5 mT |
Giorgi G et al. | 2014 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Del Giudice E et al. | 2007 | intact cell/cell culture, human neuroglioma cell line (H4; cells transfected with the human amyloid precursor protein (APP)) | magnetic field, 50/60 Hz | 3.1 mT |
Kayhan H et al. | 2020 | intact cell/cell culture, human, neonatal, healthy primary dermal fibroblast and MCF7 cells (human metastatic breast cancer cells) | magnetic field, 50/60 Hz, low frequency | - |
Ansari RM et al. | 2000 | intact cell/cell culture, human-hamster hybrid cells | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Nakayama M et al. | 2016 | intact cell/cell culture, macrophages (RAW 246) | magnetic field, 50/60 Hz, co-exposure | 500 µT |
Sun C et al. | 2018 | intact cell/cell culture, mouse embryonic fibroblasts (wild type and <i>Atm</i>-deficient) | 50/60 Hz, magnetic field | 2 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.